Rothschild & Co Asset Management US’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Rothschild & Co Asset Management US’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-107,406	Closed	-$3.21M	–	365
2014 Q3	$3.21M	Sell	107,406 -7,320	-6%	-$155K	0.07%	295
2014 Q2	$2.3M	Sell	114,726 -2,245	-2%	-$51.5K	0.05%	323
2014 Q1	$3.18M	Sell	116,971 -13,168	-10%	-$350K	0.07%	312
2013 Q4	$2.7M	Sell	130,139 -2,130	-2%	-$40.2K	0.06%	326
2013 Q3	$2.41M	Sell	132,269 -11,284	-8%	-$204K	0.05%	325
2013 Q2	$2.39M	Buy	+143,553	New	+$2.29M	0.06%	323

Other funds holding AUXL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rothschild & Co Asset Management US's AUXL Position: Q4 2014 in Review

Rothschild & Co Asset Management US sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014, closing a stake of 107,406 shares — an estimated $3.21M sold.

Rothschild & Co Asset Management US first reported a position in AUXL in Q2 2013 and held it in 6 quarters. The position peaked at $3.21M in Q3 2014. 158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

Rothschild & Co Asset Management US reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2014 after selling out during the quarter.
Rothschild & Co Asset Management US sold 107,406 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2014, an estimated $3.21M.
Rothschild & Co Asset Management US first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 6 quarters.
Rothschild & Co Asset Management US's AUXILIUM PHARAMCEUTICALS INC position peaked at $3.21M in Q3 2014.
158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2014, filed 17 Feb 2015.